When a replicative DNA polymerase stalls upon encountering a lesion on the template strand, it is relieved by other low-processivity polymerase(s), which insert nucleotide(s) opposite the lesion, extend by a few nucleotides, and dissociate from the 3'-OH. The replicative polymerase then resumes DNA synthesis. This process, termed translesion replication (TLS) or replicative bypass, may involve at least five different polymerases in mammals, although the participating polymerases and their roles have not been entirely characterized. Using siRNAs originally designed and an alkaline sucrose density gradient sedimentation technique, we verified the involvement of several polymerases in ultraviolet (UV) light-induced TLS in HeLa cells. First, siRNAs to Rev3 or Rev7 largely abolished UV-TLS, suggesting that these 2 gene products, which comprise Polζ, play a main role in mutagenic TLS. Second, Rev1-targeted siRNA also abrogated UV-TLS, indicating that Rev1 is also indispensable to mutagenic TLS. Third, Polη-targeted siRNA also prevented TLS to a greater extent than our expectations. Forth, although siRNA to Polι had no detectable effect, that to Polκ delayed UV-TLS. To our knowledge, this is the first study reporting apparent evidence for the participation of Polκ in UV-TLS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997509PMC
http://dx.doi.org/10.4061/2010/750296DOI Listing

Publication Analysis

Top Keywords

rev3 rev7
8
ultraviolet light-induced
8
translesion replication
8
hela cells
8
alkaline sucrose
8
sucrose density
8
density gradient
8
gradient sedimentation
8
mutagenic tls
8
tls
5

Similar Publications

Probing hot spots of protein-protein interactions mediated by the safety-belt region of REV7.

Structure

November 2024

Department of Pharmaceutical Sciences, University of Connecticut, 69 N Eagleville Rd, Unit 3092, Storrs, CT 06269-3092, USA. Electronic address:

REV7 is a HORMA (Hop1, Rev7, Mad2) family adaptor protein best known as an accessory subunit of the translesion synthesis (TLS) DNA polymerase ζ (Polζ). In this role, REV7 binds REV3, the catalytic subunit of Polζ, by locking REV7-binding motifs (RBMs) in REV3 underneath the REV7 safety-belt loop. The same mechanism is used by REV7 to interact with RBMs from other proteins in DNA damage response (DDR) and mitosis.

View Article and Find Full Text PDF

Mad2B forms a complex with Cdc20, Cdc27, Rev3 and Rev1 in response to cisplatin-induced DNA damage.

Korean J Physiol Pharmacol

September 2023

Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK.

Article Synopsis
  • - Mitotic arrest deficient 2 like 2 (Mad2L2 or Mad2B) is a key regulatory protein similar to yeast's Rev7, involved in the DNA damage response triggered by the chemotherapy drug cisplatin.
  • - Research shows that Mad2B is recruited to DNA damage sites in cancer cells after cisplatin treatment and forms a complex with Polζ-Rev1 and the APC/C subunit, Cdc27.
  • - The study reveals that Mad2B enhances APC/C activation, indicating its crucial role in the cellular response to DNA damage and the ubiquitination of related proteins during cisplatin-induced stress.
View Article and Find Full Text PDF

Rev7 is a versatile HORMA (Hop1, Rev7, Mad2) family adaptor protein with multiple roles in mitotic regulation and DNA damage response, and an essential accessory subunit of the translesion synthesis (TLS) DNA polymerase Polζ employed in replication of damaged DNA. Within Polζ, the two copies of Rev7 interact with the two Rev7-bonding motifs (RBM1 and RBM2) of the catalytic subunit Rev3 by a mechanism characteristic of HORMA proteins whereby the "safety-belt" loop of Rev7 closes on the top of the ligand. Here we report the nearly complete backbone and Ile, Val, Leu side-chain methyl NMR resonance assignments of the 27 kDa human Rev7/Rev3-RBM1 and Rev7/Rev3-RBM2 complexes (BMRB deposition numbers 51651 and 51652) that will facilitate future NMR studies of Rev7 dynamics and interactions.

View Article and Find Full Text PDF

Evolution of Rev7 interactions in eukaryotic TLS DNA polymerase Polζ.

J Biol Chem

February 2023

Department of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, Connecticut, USA. Electronic address:

Article Synopsis
  • Translesion synthesis (TLS) DNA polymerase Polζ, particularly its Rev7 subunit, is vital for DNA damage bypass during replication, working with Rev3 and Rev1.
  • Human Rev7 forms a stable head-to-head dimer with Rev3 through a mechanism typical of HORMA proteins, while yeast Rev7 (scRev7) forms an asymmetric head-to-tail dimer with a significantly smaller bonding interface.
  • Biophysical studies suggest that scRev7 does not dimerize in solution by itself or through its binding to Rev3, indicating that the dimerization seen in structures is likely due to interactions with other Polζ subunits, suggesting evolutionary changes in the dimerization mechanism.
View Article and Find Full Text PDF

CHAMP1 binds to REV7/FANCV and promotes homologous recombination repair.

Cell Rep

August 2022

Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Chief, Division of Genomic Stability and DNA Repair, Boston, MA 02215, USA; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address:

A critical determinant of DNA repair pathway choice is REV7, an adaptor that binds to various DNA repair proteins through its C-terminal seatbelt domain. The REV7 seatbelt binds to either REV3, activating translesion synthesis, or to SHLD3, activating non-homologous end joining (NHEJ) repair. Recent studies have identified another REV7 seatbelt-binding protein, CHAMP1 (chromosome alignment-maintaining phosphoprotein 1), though its possible role in DNA repair is unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!